Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Feb;47(2):389–395.

Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.

E Kuhlein, G Laurent, F Rigal, G Delsol, J Pris, J Ducos
PMCID: PMC1536522  PMID: 6978782

Abstract

Mouse erythrocyte-rosette-forming cells (MRFC) were determined in 76 cases of chronic lymphocytic leukaemia (CLL), 19 cases of centroblastic-centrocytic follicular non-Hodgkin's lymphoma (NHL), five cases of hairy cell leukaemia (HCL) and in 62 control patients. The mean percentage of MRFC in B-CLL was 54.8% +/- 24.4%, in nodular centro-follicular NHL 2.3% +/- 3%, in hairy cell leukaemia 14.6% +/-14.7% and among the controls 3.2% +/- 1.9%. Thus, MRFC appear to be an excellent marker of B-CLL and sometimes the only B cell marker as in 11 cases of SIg negative CLL. There is no correlation between the percentage of MRFC and clinical staging according to Rai classification whereas patients with stage 2 in Binet's classification (isolated splenomegaly) have a significantly lower MRFC percentage (23.4% +/- 27.7%; P less than 0.05). There is no correlation with prognosis, nor with serum Ig levels. We found no correlation with surface phenotype IgM, IgM-IgD or IgG. Thus, this study does not confirm the hypothesis that MRFC might characterize and immature stage in the B lymphocyte differentiation. However, these results are consistent with another hypothesis which states that lymphocytes in CLL possibly originate from a clonal expansion of a normal B lymphocyte subset, characterized by a low concentration of SIg and a receptor for mouse erythrocytes.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertoglio J., Peaud P. Y., Bryon P. A., Treille D., Felman P., Doré J. F. Prognostic value of mouse red cell rosette formation in chronic lymphocytic leukaemia. Biomedicine. 1976 Sep 30;25(8):277–278. [PubMed] [Google Scholar]
  2. Binet J. L., Leporrier M., Dighiero G., Charron D., D'Athis P., Vaugier G., Beral H. M., Natali J. C., Raphael M., Nizet B. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer. 1977 Aug;40(2):855–864. doi: 10.1002/1097-0142(197708)40:2<855::aid-cncr2820400239>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. Burns G. F., Cawley J. C. Spontaneous mouse erythrocyte-rosette formation: correlation with surface immunoglobulin phenotype in hairy-cell leukaemia. Clin Exp Immunol. 1980 Jan;39(1):83–89. [PMC free article] [PubMed] [Google Scholar]
  4. Catovsky D., Cherchi M., Okos A., Hegde U., Galton D. A. Mouse red-cell rosettes in B-lymphoproliferative disorders. Br J Haematol. 1976 Jun;33(2):173–177. doi: 10.1111/j.1365-2141.1976.tb03528.x. [DOI] [PubMed] [Google Scholar]
  5. Cherchi M., Catovsky D. Mouse RBC rosettes in chronic lymphocytic leukaemia: different expression in blood and tissues. Clin Exp Immunol. 1980 Feb;39(2):411–415. [PMC free article] [PubMed] [Google Scholar]
  6. Dighiero G., Bodega E., Mayzner R., Binet J. L. Individual cell-by-cell quantitation of lymphocyte surface membrane Ig in normal and CLL lymphocyte and during ontogeny of mouse B lymphocytes by immunoperoxidase assay. Blood. 1980 Jan;55(1):93–100. [PubMed] [Google Scholar]
  7. Dighiero G., Charron D., Debre P., Le Porrier M., Vaugier G., Follezou J. Y., Degos L., Jacquillat C., Binet J. L. Identification of a pure splenic form of chronic lymphocytic leukaemia. Br J Haematol. 1979 Feb;41(2):169–176. doi: 10.1111/j.1365-2141.1979.tb05845.x. [DOI] [PubMed] [Google Scholar]
  8. Foa R., Catovsky D., Brozovic M., Marsh G., Ooyirilangkumaran T., Cherchi M., Galton D. A. Clinical staging and immunological findings in chronic lymphocytic leukemia. Cancer. 1979 Aug;44(2):483–487. doi: 10.1002/1097-0142(197908)44:2<483::aid-cncr2820440217>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  9. Forbes I. J., Zalewski P. D. A subpopulation of human B lymphocytes that rosette with mouse erythrocytes. Clin Exp Immunol. 1976 Oct;26(1):99–107. [PMC free article] [PubMed] [Google Scholar]
  10. Gupta S., Good R. A., Siegal F. P. Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders. Clin Exp Immunol. 1976 Nov;26(2):204–213. [PMC free article] [PubMed] [Google Scholar]
  11. Gupta S., Good R. A., Siegal F. P. Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol. 1976 Aug;25(2):319–327. [PMC free article] [PubMed] [Google Scholar]
  12. Gupta S., Grieco M. H. Rosette formation with mouse erythrocytes: probable marker for human B lymphocytes. Int Arch Allergy Appl Immunol. 1975;49(6):734–742. doi: 10.1159/000231457. [DOI] [PubMed] [Google Scholar]
  13. Gupta S., Pahwa R., O'Reilly R., Good R. A., Siegal F. P. Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci U S A. 1976 Mar;73(3):919–922. doi: 10.1073/pnas.73.3.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jayaswal U., Roath S., Hyde R. D., Chisholm D. M., Smith J. L. Blood lymphocytes surface markers and clinical findings in chronic lympoproliferative disorders. Br J Haematol. 1977 Oct;37(2):207–215. doi: 10.1111/j.1365-2141.1977.tb06836.x. [DOI] [PubMed] [Google Scholar]
  15. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Knapp W., Schuit H. R., Bolhuis R. L., Hijmans W. Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis. Clin Exp Immunol. 1974 Apr;16(4):541–552. [PMC free article] [PubMed] [Google Scholar]
  17. Koziner B., KEmpin S., Gee T., Lee B. J., Good R. A., Clarkson B. D. Cell-marker analysis of complete remissions in chronic B-cell leukaemias. Lancet. 1979 Jan 20;1(8108):158–158. doi: 10.1016/s0140-6736(79)90551-8. [DOI] [PubMed] [Google Scholar]
  18. McLaughlin H., Wetherly-Mein G., Pitcher C., Hobbs J. R. Non-immunoglobulin-bearing 'B' lymphocytes in chronic lymphatic leukaemia? Br J Haematol. 1973 Jul;25(1):7–14. doi: 10.1111/j.1365-2141.1973.tb01711.x. [DOI] [PubMed] [Google Scholar]
  19. Michlmayr G., Huber H. Receptor sites for complement on certain human peripheral blood lymphocytes. J Immunol. 1970 Sep;105(3):670–676. [PubMed] [Google Scholar]
  20. Moretta L., Ferrarini M., Durante M. L., Mingari M. C. Expression of a receptor for IgM by human T cells in vitro. Eur J Immunol. 1975 Aug;5(8):565–569. doi: 10.1002/eji.1830050812. [DOI] [PubMed] [Google Scholar]
  22. Preud'Homme J. L., Brouet J. C., Seligmann M. Membrane-bound IgD on human lymphoid cells, with special reference to immunodeficiency and immunoproliferative diseases. Immunol Rev. 1977;37:127–151. doi: 10.1111/j.1600-065x.1977.tb00248.x. [DOI] [PubMed] [Google Scholar]
  23. Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood. 1975 Aug;46(2):219–234. [PubMed] [Google Scholar]
  24. Stathopoulos G., Elliott E. V. Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals. Lancet. 1974 Apr 6;1(7858):600–601. doi: 10.1016/s0140-6736(74)92655-5. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES